
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Royalty Pharma PLC is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The company assembles a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry's therapies, which includes royalti... Royalty Pharma PLC is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The company assembles a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry's therapies, which includes royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica, Astellas and Pfizer's Xtandi, Biogen's Tysabri, Johnson & Johnson's Tremfya, Gilead's Trodelvy, Merck's Januvia, Novartis' Promacta, Vertex's Kalydeco, Orkambi, Symdeko and Trikafta, and ten development-stage product candidates. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.19 | 0.523127753304 | 36.32 | 36.56 | 35.22 | 3735960 | 35.69208477 | CS |
4 | 1.59 | 4.55326460481 | 34.92 | 36.56 | 34.39 | 4013642 | 35.56404717 | CS |
12 | 3.85 | 11.7881200245 | 32.66 | 36.56 | 31.58 | 4743643 | 33.84438355 | CS |
26 | 6.61 | 22.1070234114 | 29.9 | 36.56 | 29.66 | 4719249 | 32.97298487 | CS |
52 | 9.61 | 35.7249070632 | 26.9 | 36.56 | 24.05 | 3708081 | 30.76925024 | CS |
156 | -5.82 | -13.7491141035 | 42.33 | 44.66 | 24.05 | 2692124 | 31.7206088 | CS |
260 | -7.49 | -17.0227272727 | 44 | 53.23 | 24.05 | 2465467 | 35.32475707 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions